GenoGenix LLC recalls BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW
Recalled October 15, 2025 · FDA recall D-0086-2026 · GenoGenix
Hazard
Lack of Assurance of Sterility · FDA Class II
Sold at
US Nationwide.
Description
Lack of Assurance of Sterility
Product
BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI).
Manufacturer(s)
GenoGenix LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →